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Abstract
A historical review is provided of the various methods used for half a century to
differentiate and type Chlamydia trachomatis strains. Typing of C. trachomatis is an
important tool for revealing transmission patterns in sexual networks, and
enabling association with clinical manifestations and pathogenicity. Serotyping
using the major outer membrane protein (MOMP) has been the mainstay of
epidemiological work for several decades. However, the development of nucleic
acid amplification techniques (NAAT) and easy access to sequencing have shifted
the focus from MOMP serotypes to omp1 genotypes. However, insufficient
epidemiological resolution is achieved by characterization of both MOMP and
omp1. This calls for new high-resolution genotyping methods applying for
example a multilocus variable number tandem repeat assay (MLVA) or multilocus
sequence typing (MLST). The futuristic nanotechnology already seems at hand to
further simplify and automate the high-resolution genotyping method based on
NAAT and sequencing of various targets in the C. trachomatis genome. Thereby, a
high throughput can be achieved and more epidemiological information can be
obtained. However, it is important to realize that culture of C. trachomatismay still
be needed to detect and characterize new variants of C. trachomatis.
Introduction
Since Chlamydia trachomatis was first isolated in 1957 by
professor Tang, who initially recognized it as of viral origin
(Tang et al., 1957), extensive efforts have been made towards
development of methods to characterize this important
pathogen into different types. Chlamydia trachomatis may
cause infection in a variety of body sites including the eye
and the urogenital tract. Diseases caused by C. trachomatis
include trachoma, the world’s leading cause of preventable
blindness, which still affects tens of millions of people
especially in developing countries (Kasi et al., 2004). Ur-
ogenital infections include urethritis, epididymitis, cervici-
tis, salpingitis and pelvic inflammatory disease (Cates &
Wasserheit, 1991). Severe sequelae may follow an infection,
causing ectopic pregnancy and infertility (Cates & Wasser-
heit, 1991; Svenstrup et al., 2007). Lymphogranuloma
venereum (LGV), a severe infection leading to lymphadeno-
pathy, genital ulceration, proctitis, strictures and formation
of fistulae, is endemic in many developing countries, but has
only sporadically been found in Europe for decades (Mabey
& Peeling, 2002). Recently, attention has been focused on
the disease, because it is now spreading in men who have sex
with men in Western countries (Nieuwenhuis et al., 2003;
Klint et al., 2006; Stary et al., 2008).
Other agents of the genera Chlamydia and Chlamydophila
are associated with a large variety of diseases (Corsaro et al.,
2003) for example respiratory infections and cardiovascular
diseases in humans (Chlamydophila pneumoniae). In ani-
mals, the species Chlamydophila psittaci, Chlamydophila
abortus, Chlamydophila pecorum and Chlamydia suis cause
infections in birds, sheep, goats, cattle and swine. Zoonotic
infections in humans are mainly caused by Cp. psittaci,
leading to pneumonia, but also by C. abortus, causing
abortion, and Chlamydophila felis, causing keratoconjuncti-
vitis. The main focus of this mini review is genetic typing of
C. trachomatis, but it partly covers other species in the
family Chlamydiaceae. We provide an overview of the
different typing techniques that have been applied and
discuss upcoming technologies. The various methods are
summarized in Table 1.
Why type C. trachomatis ?
There are several reasons and applications for typing. (1)
Differentiation of C. trachomatis strains can reveal
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transmission patterns in sexual networks and may be used as
a tool in partner notification. (2) It may also enable
association with clinical manifestations and pathogenicity.
(3) Furthermore, tissue or organ affinity for certain strains
may be discovered. (4) Typing of C. trachomatis may also
play a role in cases of sexual abuse or assaults. (5) Typing
may help determine whether infections are persistent or
new. (6) For evolutionary surveillance of specific clones.
Omp1 (ompA), the gene encoding the major outer
membrane protein (MOMP), has been used widely for
molecular epidemiology, especially in Sweden, where part-
ner notification has been mandatory since 1988 (Jurstrand
et al., 2001; Falk et al., 2003; Lysen et al., 2004; Osterlund
et al., 2005).
A number of reports have been published on clinical
manifestations and serotype, and the conclusions are con-
tradictory. van Duynhoven et al. (1998), in a study including
175 men and 135 women attending an STD clinic, reported
a correlation between urethral discharge in men and ser-
otypes H and J, and in women lower abdominal pain was
predominantly associated with serotypes F and G. More
reports on other associations have been published (Batteiger
et al., 1989; Dean et al., 1995; van de Laar et al., 1996; Sylvan
et al., 2002; Gao et al., 2007). Several larger studies have
found no association between serotypes and clinical mani-
festations (Persson & Osser, 1993; Stothard et al., 1998;
Ngandjio et al., 2003; Lysen et al., 2004; Millman et al.,
2006), and the majority of evidence seems to point in the
direction of no correlation.
A role for typing of C. trachomatis in cases of sexual abuse
or assaults. Although culture is recommended for investiga-
tions, the current guidelines accept the use of nucleic
acid amplification tests for detection (Centers for Disease
Control and Prevention, Workowski & Berman, 2006).
Discrimination of C. trachomatis strains may improve such
investigations, similar to the use of genetic fingerprinting of
human DNA.
Another important issue is that many patients are repeat-
edly found to be positive for C. trachomatis DNA, and
when omp1 was typed a large proportion were found to be
of the same serotype (Dean et al., 2000; Pedersen et al.,
2000). Because serotype E is by far the most prevalent,
it can be difficult to determine whether an infection is
persistent or recurrent, and it is important that methods
with a higher degree of resolution are applied to resolve this
interesting question. Using high-resolution typing in a
Danish study, a particular association with a certain geno-
type for persistent infections could not be established
(Pedersen et al., 2008).
A unique opportunity to study the spread and evolution
of a strain emerged when a new variant C. trachomatis
(nvCT) strain was discovered in Halmstad, Sweden, in 2006
(Ripa & Nilsson, 2007). This strain is characterized by a 377-
bp deletion in the cryptic plasmid, and because the primers
Table 1. Characteristics of various methods for typing Chlamydia trachomatis
Method
Culture Detect mixed
Principle Target Depended Reference Culture Comment
MTPT Immunization Unknown Yes Wang & Grayston (1963) NA Proof of existence of different types
Microimmunofluorescens Immunization Unknown Yes Wang et al. (1975) NA Crossactivity between types
Polyclonal antibodies Serotyping MOMP Yes Wang et al. (1973b) Yes Crossactivity between types
Monoclonal antibodies Serotyping MOMP Yes Stephens et al. (1982),
Wang et al. (1985)
Yes Crossactivity between types
RIA Serotyping MOMP Yes Van Der Pol & Jones (1992) Yes Crossactivity between types
Dot-ELISA Serotyping MOMP Yes Barnes et al. (1987) Yes Crossactivity between types
PCR-RFLP Genotyping omp1 Yes Rodriguez et al. (1991) Yes 13 of 15 serovars identified
PCR-RFLP Genotyping omp1 No Lan et al. (1993) Yes Cervical scrapes used
PFGE Genotyping Genomic DNA Yes Birkelund & Stephens (1992) No Purification of EBs needed
RAPD Random DNA Genomic DNA Yes Scieux et al. (1993) NA Do not reflect serovars
PCR Genotyping omp1 No Pecharatana et al. (1993) Yes Fluorophore marked primers.
Only serotypes A, B, C detected
AFLP Genotyping Genomic DNA Yes Morre et al. (2000a) NA Difficult to standardize
Reverse line blot Genotyping omp1 No Quint et al. (2007) Yes Low technology detection
PCR1sequencing Genotyping omp1 No Lysen et al. (2004) No Serotype-level typing
Real-time PCR Genotyping omp11pmp-H No Schaeffer & Henrich (2008) Yes L-serovars only
PCR1sequencing Genotyping MLST No Klint et al. (2007) No Subtyping serotypes
PCR1sequencing Genotyping omp11VNTR No Pedersen et al. (2008) No Subtyping serotypes
Suspension array Genotyping omp1 No Huang et al. (2008) Yes Serotype-level typing
The different techniques in Table 1 have also been applied on other Chlamydiaceae species, but references are not included here.
NA, not applicable, ELISA, enzyme-linked immunosorbent assay; AFLP, amplified fragment length polymorphism.
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for some of the commercial detection systems were directed
to the deleted area, the strain was able to spread freely. The
strain has been recognized as a serotype E, and further
typing using new systems (Herrmann et al., 2008; Pedersen
et al., 2008) has strongly suggested the spread of a single
clone. It will be very interesting to follow the development
and spread of this particular clone.
The early days: MOMP
In the 1960s, Wang & Grayston (1963) developed the mouse
toxicity prevention test (MTPT). They inoculated egg yolk
sacs with ‘Trachoma-inclusion conjunctivitis organisms’.
Crude extracts of these were intravenously injected into
mice, which triggered an immune response. Subsequently,
the mice were challenged with intravenous injections of the
same or different isolates of Chlamydia. A protective me-
chanism in the mice that received the same isolate during
the challenge plus some cross-protection from other isolates
was reported (Wang & Grayston, 1963). In this way, they
demonstrated the presence of different types of Chlamydia.
The authors report that it took 7 years to classify 80 strains
of C. trachomatis using the MTPT into six immunological
types (Wang et al., 1985), and obviously more simple tests
were needed for epidemiological studies. Subsequently, they
developed a microimmunofluorescence test (Wang & Grays-
ton, 1970; Wang et al., 1973a). The test is based on
elementary bodies (EBs) of known type grown in yolk sacs,
and polyvalent antiserum produced in mice. In the 1960s,
where culture of cells with inclusion bodies had become
applicable (Gordon et al., 1969), researchers identified 13
different Chlamydia types based on surface antigens, includ-
ing the now well-known A, Ba, B, C, D, E, F, G, H, I and L1-
L3 (Wang & Grayston, 1970, 1975; Wang et al., 1973a; Kuo
et al., 1974). Later, types Ia, J, Ja and K were identified,
resulting in a recognized total of 17 known different
serotypes. This grouping is still in use.
Microimmunofluorescence was hampered by crossreac-
tivity between related types, and the polyclonal antibodies
were later replaced by more specific monoclonal antibodies
(mAb) (Stephens et al., 1982; Wang et al., 1985).
It was recognized that the epitopes for the antibodies were
located on the MOMP of the organism (Stephens et al.,
1982; Bell et al., 1984). Almost all subsequent typing
schemes have focused on this protein or the gene encoding
it, omp1. mAb were further refined, which improved the test
specificity and sensitivity (Stephens et al., 1982; Wang et al.,
1985; Barnes et al., 1987). Using these new panels of
antibodies, it was possible to differentiate between serovars.
This typing system was used until sequencing became
available.
New tests based on fluorescence and radio immunoassays
were later developed and compared (Van Der Pol & Jones,
1992), and commercially available antibody panels became
available (Suchland & Stamm, 1991; Ossewaarde et al.,
1994). A dot-ELISA method (Barnes et al., 1985) made
typing of large numbers of C. trachomatis possible, and soon
studies on tissue/organ tropism of serovars were published
(Barnes et al., 1987; Wagenvoort et al., 1988). Serovars and
organ trophism are summarized in Table 2.
All the above-described techniques require culturing of
C. trachomatis, which is expensive, time consuming and
requires expert staff and facilities. Another drawback of the
methods is that serovars unrecognized by the antibody
panels available might evolve, a matter of concern already
brought to light in early work (Wang et al., 1985; Barnes
Table 2. Serovars and organ trophism in C. trachomatis
Class Serovar Clade (pmpH-genes)w Infections
B B Ocular trachoma clade Eye (urogenital)
Ba Ocular trachoma clade Eye (urogenital)
D STD clade Urogenital
E STD clade Urogenital
L1 LGV clade Lymphogranuloma venereum
L2 LGV clade Lymphogranuloma venereum
C A Ocular trachoma clade Eye
C Ocular trachoma clade Eye
H STD clade Urogenital
I (Ia) STD clade Urogenital
J (Ja) STD clade Urogenital
K STD clade Urogenital
L3 LGV clade Lymphogranuloma venereum
Intermediate complex G STD clade Urogenital
F STD clade Urogenital
Based on Wang et al. (1985).
wBased on Stothard et al. (2003).
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et al., 1987). It should also be noted that the sensitivity of
culture is often less than for the routinely used nucleic acid
amplification techniques (NAAT) assays (Burckhardt et al.,
2006), further hampering the typing of clinical cases of
Chlamydia infection.
Molecular methods: Omp1
PCR and restriction fragment length
polymorphism (RFLP)
With the ingenious invention of PCR by Kary Mullis in
1983, the era of molecular or genotyping began. In the
1990s, PCR was often followed by RFLP, and DNA patterns
resolved on gels. The patterns were found to be compatible
with the results obtained by serotyping. Rodriguez et al.
(1991) amplified 1200 bases of the omp1 gene and the
product was digested by restriction nucleases, and resolved
on polyacrylamide gels. Thirteen of the 15 serovars could be
differentiated by this technique. Several studies followed and
extended batteries of restriction enzymes were applied
(Sayada et al., 1991; Morre et al., 1998).
Omp1 is a single copy gene, and to obtain adequate
material for RFLP, Frost et al. (1993) improved the PCR
yield using nested primers. They reported the distribution
of C. trachomatis types in 46 clinical samples in Canada,
showing that serovar E is by far the most prevalent
type, followed by serovars D and F. This distribution of
serovars with only small variations has later been found
in several studies in heterosexual populations all over
the world (Borrego et al., 1997; Jurstrand et al., 2001;
Singh et al., 2003; Ngandjio et al., 2004; Yamazaki et al.,
2005; Gao et al., 2007; Takahashi et al., 2007). However,
in men having sex with men, the predominant serovars
are G, D and J (Geisler et al., 2002; Lister et al., 2004;
Klint et al., 2006).
A study also pointed out that type E was not only the
most prevalent type but also very stable, with few changes
even between strains of different geographical origins,
as illustrated by isolates collected in France and Sweden
(Rodriguez et al., 1993). It was subsequently shown
that PCR could be made directly from cervical scrapes
(Lan et al., 1993), which made typing possible for labora-
tories without access to culture facilities. The strength of
PCR–RFLP methods is their ability to detect mixed infec-
tions, but this ability may be overestimated because PCR
will favor the most abundant serovar, and the others may
remain undetected or may show only dim RFLP bands
(Yang et al., 1993). PCR and RFLP are still often applied
and have been used for analysis of samples from LGV
patients (Herida et al., 2006; Waalboer et al., 2006), which
may be relevant because only three different genotypes need
to be differentiated.
PCR and sequencing
With automation and the availability of fluorophore-
marked nucleotides, it became possible for routine labora-
tories with no culture facilities to perform sequencing. It was
shown that sequence determination of omp1 provided a
higher resolution than serotyping and RFLP (Yang et al.,
1993; Quinn et al., 1996; Morre et al., 1998, 2000a, b), and at
present the state-of-the-art method for typing is sequencing.
A drawback is the difficulties in resolving mixed infections
because peaks from different PCR products will be super-
posed in the chromatograms from sequencing reactions.
The variability in omp1 sequences measured as the
number of genetic variants as a proportion of all Chlamydia
cases ranges between 16% and 81% in various studies (Dean
et al., 1995; Pedersen et al., 2000; Sturm-Ramirez et al.,
2000). However, in these studies, the numbers of cases were
low (fewer than 70) and/or the study populations were
recruited from high-risk groups. In a study of all cases
detected in 1 year in a Swedish county, 29 (4.3%) genetic
variants were found among 678 omp1 sequences (Lysen
et al., 2004). Furthermore, in the most prevalent serotype
E, only 3.6% diverged from the reference sequence, which
contrasts with a previous study in which 16% of 67 E strains
represented genetic variants (Dean & Millman, 1997), but is
in agreement with other reports (Jurstrand et al., 2001;
Jonsdottir et al., 2003). Thus, in unselected populations
omp1 sequence analysis has limited discrimination for
genotyping C. trachomatis strains. In a recent study (Ped-
ersen et al., 2008), Simpson’s index of diversity (Hunter &
Gaston, 1988; Hunter, 1990) (D) for omp1 was reported to
be 0.69 when omp1 of 93 epidemiologically unrelated strains
were sequenced. In the consensus guidelines by the Eur-
opean Society of Clinical Microbiology and Infectious
Diseases (ESCMID) Study Group on Epidemiological Mar-
kers (ESGEM), a typing system should have a D of no
o 0.95 (van Belkum et al., 2007).
Other methods
Several other methods have been developed for genotyping
of C. trachomatis using omp1 as a target. For the three L-
serovars, genotyping has been enabled by real-time PCR
targeting the omp1 gene and an L-serovar specific gap in the
polymorphic protein H (pmpH) (Schaeffer & Henrich,
2008). Differentiation between the three L-serovars was
accomplished by a second real-time PCR targeting the
serovar-specific regions of the omp1. The advantages
of the method are the capacity to detect mixed infections,
and that no sequencing instrument is required. However, two
real-time PCR runs are required to determine the genotypes.
Pulsed field gel electrophoresis (PFGE) requires pure
bacterial DNA, and thus culture of C. trachomatis and
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purification of EBs is necessary to obtain DNA patterns
related to C. trachomatis without interfering with the host
DNA. The method has been used to generate a genetic map
for serovar L2 (Birkelund & Stephens, 1992). For genetic
variability, PFGE has been assessed in a study of a reference
panel and was found to be less discriminative than serotyp-
ing or omp1 genotyping (Rodriguez et al., 1994).
Random amplification of polymorphic DNA (RAPD)
using four single 10-mer primers was applied to 39
C. trachomatis samples plus one Cp. pneumoniae and two
Cp. psittaci strains (Scieux et al., 1993). The authors found
that RAPD did not reflect serotyping, but suggested it could
be used as a supplement to omp1 typing, indicating the
inadequacy of both methods when used alone.
The related technique of amplified fragment length poly-
morphism (AFLP) uses restriction enzymes to cut genomic
DNA, followed by ligation of adaptors to the ends of the
restriction fragments. A subset of the restriction fragments are
then amplified and visualized on gels. The technique requires
genomic DNA culturing, and purification of EBs is necessary.
Despite claiming that the differences are reproducible (Morre
et al., 2000a), the authors recommend that strains be analyzed
in the same PCR run and the same polyacrylamide gel, which
implies that the method is not easy to handle.
A single tube nested PCR for genotyping of ocular strains
was developed (Pecharatana et al., 1993). Inner primers were
labeled with genotype-specific fluorescent dyes for types A,
B and C, and detected by denaturing polyacrylamide gel
electrophoresis and GENESCAN software.
The method is able to detect mixed infections, but
requires special equipment, and is not applicable to urogen-
ital infections because these include other and more types of
C. trachomatis. Only a few detection channels are available
on the commercially available instruments. This problem is
highlighted in a study where an elaborate panel of primers,
TaqMan probes and several PCRs are used to detect the
omp1 genotypes of the serovars that cause sexually trans-
mitted disease (Jalal et al., 2007).
The detection problem can be overcome if Microsphere
suspension arrays are used (Huang et al., 2008). These
suspension array systems (Luminex 100 and Bio-Plex 200)
allow the detection of up to 100 different biomolecules
(proteins and nucleic acids) in a 96-well plate. The real
challenge is to design a well-functioning multiplex PCR with
a sensitivity comparable to single plex assays, with a large
number of primers and probes that do not interact. When
this is accomplished, the systems are easy to handle, require
special instruments, but are economical and time saving
compared with PCR and sequencing. Furthermore, the
system enables detection of mixed infections. Huang et al.
(2008) constructed a panel of primers and probes covering
the serotypes responsible for urogenital infections, except
type I.
Low-technology typing can be accomplished by a
reverse line blot for which several different designs have
been made (Molano et al., 2004; Xiong et al., 2006; Quint
et al., 2007; Zheng et al., 2007). Generally, serotype-specific
detection probes are blotted onto nylon membranes, and
PCR products are generated using poly-T-labeled primers
that target either different sites of both variable and constant
segments of the omp1 gene, biotinylated primers targeting
the variable segment VS2 (Molano et al., 2004; Xiong et al.,
2006; Quint et al., 2007) or the VS1–VS2 of the omp1 gene
(Zheng et al., 2007). Positive samples are detected by
enzyme-based colorimetric reactions or chemiluminescense.
The drawback of the method is that it resolves genotypes
only at the omp1 level, and , because of the probe detection,
it may miss subtle changes in the omp1, for example point
mutations, which are the most frequently found alterations
in this gene. The advantages are that it may identify mixed
infections, and that it requires only low technology to
perform. Thus, genotyping of samples from 5829 women
18–25 years old in the developing country Costa Rica
(Porras et al., 2008) was performed on samples resolved in
vials containing PreservCyt solution as part of enrollment in
a community-based trial investigating the efficacy of the
HPV 16/18 vaccine.
Targets other than omp1
Other targets for epidemiology of C. trachomatis have rarely
been studied. Stothard et al. (2003) hypothesized that a
family of nine polymorphic membrane protein genes (pmpA
to pmpI) would possess a sequence variability that would be
useful for epidemiology. They found that the pmp genes
were remarkably conserved, and therefore not suited for the
intended use. The pmpH genes, however, in contrast to the
omp1 genes, clustered into three clades that are compatible
with the disease group (see Table 2).
Contemporary typing systems
As seen above, none of the tested target genes provide
sufficient discrimination of C. trachomatis strains, and there
is an obvious need for better genotyping systems. Recently,
two alternative detection systems have been reported to
provide high-resolution typing of C. trachomatis and of
other Chlamydiaceae species.
Multiple loci variable number of tandem repeats
(VNTR) analysis (MLVA)
A combination of PCR and sequencing of omp1 plus three
loci of VNTR has been proposed as a means to obtain higher
diversity (Pedersen et al., 2008).
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This approach shows a Simpson’s index of diversity of
0.94, which is very close to the diversity index of 0.95
recommended for new typing methods (van Belkum et al.,
2007). This method is by far more discriminative than omp1
alone (D= 0.69), but has the same disadvantage as all PCR-
and sequencing-based assays: the inability to detect mixed
infections. Also, four PCRs and sequences are required,
although the scheme might be simplified using the VNTRs
sequentially for example the most discriminative first and, if
needed, the other two, instead of all at one time. The choice
of VNTRs as single nucleotide repeats ensures a high degree
of variation; yet the authors found the three loci to be stable
in 24 patients who experienced persistent or recurrent
C. trachomatis infections. The PCR and sequencing of three
loci of repeats (see Fig. 1) were readily performed on
samples placed in the transport media for the routine assay
for C. trachomatis.
MLVA has also been applied for high-resolution typing of
170 Cp. psittaci strains from birds of different species and
geographical origins (Laroucau et al., 2008). The system is
based on eight loci with tandem repeats and generated 20
distinct patterns compared with seven genotypes by PCR-
RFLP, a standard method for high-volume typing of
Cp. psittaci strains in birds.
Multilocus sequence typing (MLST)
High-resolution typing of C. trachomatis strains has been
achieved by sequence determination of five genomic targets
in the genome (see Fig. 2) plus omp1. Analysis of 47 clinical
isolates of representative serotypes resulted in 32 genetic
variants among 12 omp1 variants (Klint et al., 2007). It was
also applied to differentiate serotype E strains with identical
omp1 from sexual networks. Although there are limitations
to the use of the MLST system, it was shown that it can be
used on clinical specimens from routine NAAT diagnostics.
An alternative MLST system has also been developed for
the entire Chlamydiaecae family (Pannekoek et al., 2008). It
is based on seven housekeeping genes and analyzes evolu-
tional changes rather than acting as a tool for partner
notification. It could discriminate reference strains of
C. trachomatis, but was evaluated on too few clinical strains
to assess the discriminatory capacity. In an analysis of 18
strains of Cp. pneumoniae, three point mutations were seen
in only two strains, i.e. the MLSTsystem provides almost no
resolution for Cp. pneumoniae.
Nomenclature
For decades, chlamydiologists have focused on serovars and
omp1 for typing. The advent of new multitarget typing
systems provides more information and highlights the need
for standardized nomenclature systems. User-friendly typ-
ing systems require easy interpretation and communication
of data. This is an urgent challenge that needs to be resolved.
Future perspectives
Array technology is developing rapidly, and the proof of the
principle has been shown for C. trachomatis (Ehricht et al.,
2006) and has recently been applied for genotyping omp1 in
Cp. psittaci strains (Sachse et al., 2008). A similar array, but
designed for identification of all Chlamydiaceae species, has
been shown to work on different kinds of clinical samples
(Borel et al., 2008). It might be possible to achieve a higher
discrimination by spot probes for the different MLST targets
(Klint et al., 2007) or VNTR targets (Pedersen et al., 2008) to
solid arrays or perhaps suspension arrays. Other targets may
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Fig. 1. VNTRs and genomic context. Approximate position of primers are marked with vertical arrows.
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be found in the genomes of Chlamydiaceae, but still need to
be identified and validated.
Albeit futuristic, the future is already here. Whole-gen-
ome sequencing or high-volume analysis of DNA could be
an option for characterization of strains. Vast amounts of
information will be generated in this way, and close co-
operation with bio-informaticians will be crucial.
Virtually all the techniques described in this mini review
and used at present require target amplification by PCR, and
thus are dependent on the sensitivity and specificity of the
PCR. They are also limited by primer and probe interac-
tions, and by the number of detection channels on the
instruments available. Nanotechnology may be a future
solution to these problems. Already, several reports on
DNA and RNA detection using surface plasmon resonance
and gold nanoparticle probes, without previous amplifica-
tion, have been published (Storhoff et al., 2004; Bao et al.,
2005). A very recent publication has reported a detection
limit for single nucleotide polymorphisms down to 1 fM
using peptide nucleic acid probes and nanoparticle-
enhanced surface plasmon resonance imaging (D’Agata
et al., 2008). These techniques may also lead to a revolution
in genotyping.
Concluding remarks
A serotype based on MOMP is still a fundamental charac-
teristic of C. trachomatis strains and their organ tropism.
Important epidemiological knowledge has been obtained
through serotyping. Genotype based on PCR and sequen-
cing of omp1 coincides with the MOMP serotype and
genotyping is now replacing serotyping. However, the
insufficient epidemiological resolution achieved by charac-
terization of MOMP or omp1 makes it necessary to apply
new genotyping methods with a higher resolution, for
example MLVA and MLST.
In a historical perspective, genotyping has moved from
the egg yolk to the futuristic nanotechnology. However, it is
important to realize that culture of C. trachomatis may still
be needed to detect and characterize new variants, but we do
not have to go back to the egg yolk.
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